ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

WuXi to add vaccines to biologics in Ireland

by Rick Mullin
November 30, 2019 | APPEARED IN VOLUME 97, ISSUE 47

WuXi Biologics’ vaccines division will spend $240 million to build a facility in Dundalk, Ireland. The plant will be located on the same campus as a $390 million biologic drug manufacturing facility that the pharmaceutical services firm announced in 2018. The vaccines plant is expected to bring 200 jobs to the town, near the border with Northern Ireland. The biologics plant, which is scheduled to open in 2021, is set to add 400 jobs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment